Table 6.

Summary of clinical assays of other drugs against Enteroviruses.

Publication Date	Type of Study *	Virus/Disease	Type of Infection (Time to Treatment Interval) †	Drug	Type of Drug	Pharmaceutical Form	Patient Age	Ref.
January 1990	Rdm DB PC phase II	RV-A9, RV-B14	Inoculation (−1 day)	Nedocromil sodium	Mast cell stabilizer	Nasal spray	18–50 years old	[98]
15 April 2000	Rdm DB PC phase II	RV-A16	Inoculation (−1 day)	Clarithromycin	Antibiotic	Oral capsule	>18 years old	[100]

* Rdm = randomized; DB = double–blind; PC = placebo-controlled. ^† Negative delay means that the treatment began before the virus challenge or symptoms onset.